Hi Eddie,
Totally understand the connection between COVID-19 & DMX-700, a few of us were wondering about that before the ANN came out & the pulmonary connection there, but that is still in pre-clinical, so it kind of didn’t make sense in a PH4 trial. DMX-200 does on the new RAAS arm, and reflecting on comments from Dimerix, that we are in a unique position here, I’m just wondering when this protocol is published on REMAP-CAP website, will DMX-200 + ARB possibly be the only drug at this point in time?
It’s still an IND so that in itself to convince the International REMAP-CAP medical advisory board to include DMX-200 on the trial is pretty special, there would have to be very compelling evidence. I did bring my laptop home from work this weekend so will do some searches on CIAP & share here.
- Forums
- ASX - By Stock
- Ann: Positive Top-Line Results in DKD Phase 2 Clinical Study
Hi Eddie,Totally understand the connection between COVID-19 &...
-
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
(20min delay)
|
|||||
Last
61.0¢ |
Change
0.055(9.91%) |
Mkt cap ! $335.3M |
Open | High | Low | Value | Volume |
57.0¢ | 61.5¢ | 56.5¢ | $1.938M | 3.305M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3652 | 60.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
61.0¢ | 27035 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3652 | 0.605 |
3 | 144496 | 0.600 |
2 | 28574 | 0.595 |
2 | 28532 | 0.590 |
2 | 24412 | 0.585 |
Price($) | Vol. | No. |
---|---|---|
0.615 | 17989 | 2 |
0.620 | 30000 | 1 |
0.625 | 43532 | 2 |
0.630 | 81378 | 5 |
0.635 | 123532 | 2 |
Last trade - 16.10pm 20/06/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online